Skip to main content
Equibles
COGT logo

COGT · Cogent Biosciences, Inc. · Metrics

Track COGT — free

Use COGT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research COGT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$31.21 -0.10 (-0.32%) At close · Oct 23
Russell 2000 member Rebalance outlook locked
Market Cap
$5.42B
Shares
173.52M
Volume · Oct 23 1.77M Avg daily vol (3M) 1.96M

COGT metrics

76 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$31.21
Market cap
$5.42B

Price action

20 metrics
Price change (1W)
+5.7%
Price change (30D)
-3.4%
Price change (3M)
-21.5%
Price change (6M)
-15.2%
Price change (YTD)
-12.1%
Price change (1Y)
+110.3%
Trailing year
Price change (5Y)
+281.1%
52-week high
$42.84
52-week low
$14.13
Change from 52-week high
-27.1%
Change from 52-week low
+120.9%
Annualized volatility
127.6%
Annualized volatility (3M)
45.3%
Beta
2.6
RSI (14D)
49.4
Price vs SMA 50
-5.3%
Price vs SMA 200
-12.8%
Avg volume (3M)
1.96M
Relative volume
0.9
Average dollar volume
$67.05M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
173.52M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
688.1×
reciprocal yield 0.1%
P / book
10.2
reciprocal yield 9.8%
FCF yield
-5.7%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-7.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-05-05

Profitability

9 metrics
Gross margin
—
Operating margin
-1,044.3%
Trailing 12 months
Net margin
-950.4%
Gross profit (TTM)
—
Operating profit (TTM)
−$389.09M
Net income (TTM)
−$377.18M
Trailing 12 months
Diluted EPS (TTM)
$-2.16
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$1.03
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-2.51
EBITDA per diluted share (TTM)
$-2.49
Net income per diluted share (TTM)
$-2.44
Operating cash flow per diluted share (TTM)
$-1.98
Free cash flow per diluted share (TTM)
$-1.99
Capital expenditures per diluted share (TTM)
$0.01
R&D per diluted share (TTM)
$1.88
Stock compensation per diluted share (TTM)
$0.39
Book value per share
$3.95

Growth

11 metrics
Revenue growth YoY
-100.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$7.87M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+49.4%
Year over year · more shares
Revenue CAGR (3Y)
-2.0%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-70.8%
Return on assets
-45.2%
Debt / equity
0.4
Current ratio
13.6
EBITDA (TTM)
−$386.42M
Free cash flow (TTM)
−$309.24M
Quick ratio
13.6
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$42.28M
Latest balance sheet
Cash & equivalents
$181.17M
Total assets
$834.55M
Total debt
$223.46M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$307.55M
Capital expenditures (TTM)
$1.70M
R&D (TTM)
$290.72M
SG&A (TTM)
—
Stock compensation (TTM)
$60.37M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
327
13F filer change QoQ
+19
Institutional ownership
112.5%
Conviction holders (share of 13F filers)
4.7%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+3.1%
Holder tenure
11.9
Price vs estimated holder cost
+72.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
18.3%

Short interest

3 metrics
Short interest
11.2%
Latest settlement · 8.1 days to cover
Days to cover
8.1d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.69M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1622229 CUSIP 19240Q201 13F (30d) 29 filings 29 filers Visit website Investor relations